For example, while CAR19-iNK-like cells significantly upregulated NKp30 in response to all tested tumor cells when compared with WT-iNK-like cells, particularly at the low E:T ratios, they activated CD158 in REH cells and inhibited CD158 in Raji cells. The gene discussed is NCR3; the disease is neoplasm.